Literature DB >> 21214659

HIV infection and immune defense of the penis.

Deborah Anderson1, Joseph A Politch, Jeffrey Pudney.   

Abstract

Recent evidence that circumcision decreases HIV infection in heterosexual men by 50-60% has focused research on the foreskin as a target of HIV infection. In this review article, we discuss potential mechanisms underlying the circumcision effect and re-examine the assumption that the foreskin is the principle penile HIV infection site. HIV target cells are present in the foreskin epithelium, but are also found in the epithelia of the penile shaft, glans/corona, meatus and urethral introitus. Sexually transmitted infections (STIs) can affect any of these sites and increase susceptibility to HIV acquisition by eroding the protective epithelial layer and by attracting and activating HIV target cells in the epithelium. The moist subpreputial cavity, which encompasses the entire penile tip in most uncircumcised men including the glans, meatus and urethral introitus, plays an important role in STI acquisition. Circumcised men have a lower rate of STIs that infect not only the foreskin but also other distal penile sites, especially the urethra. Likewise, the foreskin may trap HIV and HIV-infected cells after intercourse thereby increasing the risk of HIV acquisition not only through the inner foreskin but also other sites covered by the foreskin. The subpreputial cavity also hosts a unique microbiome that may also play a role in HIV infection. We hypothesize that the penile urethra may be the primary HIV acquisition site in circumcised men and possibly also in non-circumcised men because of the presence of superficial HIV target cells and a high incidence of STIs at this site. Both innate and adaptive immune defense mechanisms are operative in the lower male genital region. The penile urethral mucosa contains accumulations of IgA(+) plasma cells and T lymphocytes and may provide a responsive target for future mucosal vaccines to prevent HIV sexual transmission.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21214659      PMCID: PMC3076079          DOI: 10.1111/j.1600-0897.2010.00941.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  46 in total

1.  TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Authors:  Marein A W P de Jong; Lot de Witte; Menno J Oudhoff; Sonja I Gringhuis; Philippe Gallay; Teunis B H Geijtenbeek
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

2.  Urethral lymphocyte isolation in non-gonococcal urethritis.

Authors:  M Shahmanesh; P G Pandit; R Round
Journal:  Genitourin Med       Date:  1996-10

3.  Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates.

Authors:  Y Ganor; Z Zhou; D Tudor; A Schmitt; M-C Vacher-Lavenu; L Gibault; N Thiounn; J Tomasini; J-P Wolf; M Bomsel
Journal:  Mucosal Immunol       Date:  2010-06-23       Impact factor: 7.313

4.  Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men.

Authors:  Taha Hirbod; Robert C Bailey; Kawango Agot; Stephen Moses; Jeckoniah Ndinya-Achola; Ruth Murugu; Jan Andersson; Jakob Nilsson; Kristina Broliden
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

5.  Foreskin length in uncircumcised men is associated with subpreputial wetness.

Authors:  N O'Farrell; C-K Chung; H A Weiss
Journal:  Int J STD AIDS       Date:  2008-12       Impact factor: 1.359

6.  Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners.

Authors:  Carrie M Nielson; Melody K Schiaffino; Eileen F Dunne; Jason L Salemi; Anna R Giuliano
Journal:  J Infect Dis       Date:  2009-01-01       Impact factor: 5.226

7.  Male circumcision for the prevention of HSV-2 and HPV infections and syphilis.

Authors:  Aaron A R Tobian; David Serwadda; Thomas C Quinn; Godfrey Kigozi; Patti E Gravitt; Oliver Laeyendecker; Blake Charvat; Victor Ssempijja; Melissa Riedesel; Amy E Oliver; Rebecca G Nowak; Lawrence H Moulton; Michael Z Chen; Steven J Reynolds; Maria J Wawer; Ronald H Gray
Journal:  N Engl J Med       Date:  2009-03-26       Impact factor: 91.245

8.  Association between HIV and subpreputial penile wetness in uncircumcised men in South Africa.

Authors:  Nigel O'Farrell; Linda Morison; Prashini Moodley; Keshree Pillay; Trusha Vanmali; Maria Quigley; Richard Hayes; A Willem Sturm
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

9.  The effects of circumcision on the penis microbiome.

Authors:  Lance B Price; Cindy M Liu; Kristine E Johnson; Maliha Aziz; Matthew K Lau; Jolene Bowers; Jacques Ravel; Paul S Keim; David Serwadda; Maria J Wawer; Ronald H Gray
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

10.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

View more
  35 in total

1.  Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques.

Authors:  Kristina Rothaeusler; Zhong-Min Ma; Huma Qureshi; Timothy D Carroll; Tracy Rourke; Michael B McChesney; Christopher J Miller
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Differential compartmentalization of HIV-targeting immune cells in inner and outer foreskin tissue.

Authors:  Aiping Liu; Yu Yang; Lu Liu; Zhefeng Meng; Liangzhu Li; Chao Qiu; Jianqing Xu; Xiaoyan Zhang
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 3.  Microbiome in human immunodeficiency virus infection.

Authors:  January T Salas; Theresa L Chang
Journal:  Clin Lab Med       Date:  2014-09-18       Impact factor: 1.935

4.  Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men.

Authors:  Joseph A Politch; Kenneth H Mayer; Seth L Welles; William X O'Brien; Chong Xu; Frederick P Bowman; Deborah J Anderson
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

5.  Barriers of Mucosal Entry of HIV/SIV.

Authors:  Ann M Carias; Thomas J Hope
Journal:  Curr Immunol Rev       Date:  2019

Review 6.  Human microbiome and HIV/AIDS.

Authors:  Deepak Saxena; Yihong Li; Liying Yang; Zhiheng Pei; Michael Poles; William R Abrams; Daniel Malamud
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

7.  Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior.

Authors:  Haile Selassie Okuku; Eduard J Sanders; Joyce Nyiro; Caroline Ngetsa; Eric Ohuma; R Scott McClelland; Matthew A Price; Susan M Graham
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

Review 8.  Does HIV Exploit the Inflammatory Milieu of the Male Genital Tract for Successful Infection?

Authors:  Rachel T Esra; Abraham J Olivier; Jo-Ann S Passmore; Heather B Jaspan; Rushil Harryparsad; Clive M Gray
Journal:  Front Immunol       Date:  2016-06-24       Impact factor: 7.561

9.  HIV-1 is undetectable in preejaculatory secretions from HIV-1-infected men on suppressive HAART.

Authors:  Joseph A Politch; Kenneth H Mayer; Deborah J Anderson
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177

Review 10.  Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.

Authors:  Philip V Nguyen; Jessica K Kafka; Victor H Ferreira; Kristy Roth; Charu Kaushic
Journal:  Cell Mol Immunol       Date:  2014-06-30       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.